Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| T. Rowe Price Group, Inc. | Institution | 11 648 346 | 15,19% | US$ 75,02M | 2026-03-31 |
| Redmile Group, LLC | Institution | 6 892 033 | 8,99% | US$ 44,38M | 2026-06-09 |
| OrbiMed Advisors LLC | Institution | 6 306 127 | 8,22% | US$ 40,61M | 2026-06-15 |
| OrbiMed Private Investments IX, LP | Institution | 5 255 106 | 6,85% | US$ 33,84M | 2026-06-15 |
| Prosight Management, LP | Institution | 5 004 439 | 6,53% | US$ 32,23M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 4 644 957 | 6,06% | US$ 29,91M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 3 706 734 | 4,83% | US$ 23,87M | 2026-06-10 |
| Deep Track Capital, LP | Institution | 3 706 734 | 4,83% | US$ 23,87M | 2026-06-10 |
| Redmile Biopharma Investments II, L.P. | Institution | 3 338 997 | 4,35% | US$ 21,50M | 2026-06-09 |
| Nextbio Capital Management Lp | Institution | 3 149 907 | 4,11% | US$ 20,29M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 2 277 176 | 2,97% | US$ 14,67M | 2026-03-31 |
| Prosight Plus Fund, LP | Institution | 1 573 872 | 2,05% | US$ 10,14M | 2024-09-30 |
| Clark Estates Inc. | Institution | 1 475 648 | 1,92% | US$ 9,50M | 2026-03-31 |
| Pinnacle Associates, Ltd. | Institution | 1 368 223 | 1,78% | US$ 8,81M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 1 159 321 | 1,51% | US$ 7,47M | 2026-03-31 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 1 051 021 | 1,37% | US$ 6,77M | 2026-06-15 |
| Point72 Asset Management, L.P. | Institution | 1 031 049 | 1,34% | US$ 6,64M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 905 707 | 1,18% | US$ 5,83M | 2026-03-31 |
| 683 Capital Management, LLC | Institution | 800 000 | 1,04% | US$ 5,15M | 2026-03-31 |
| Millennium Management LLC | Institution | 763 745 | 1,00% | US$ 4,92M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 715 965 | 0,93% | US$ 4,61M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 645 705 | 0,84% | US$ 4,16M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 604 500 | 0,79% | US$ 3,89M | 2026-03-31 |
| Marshall Wace LLP | Institution | 581 471 | 0,76% | US$ 3,74M | 2026-03-31 |
| Takeda Pharmaceutical Company Limited | Institution | 515 619 | 0,67% | US$ 3,32M | 2025-09-30 |
| BlackRock, Inc. | Institution | 510 806 | 0,67% | US$ 3,29M | 2026-03-31 |
| Redmile Capital Offshore Master Fund, Ltd. | Institution | 494 932 | 0,65% | US$ 3,19M | 2025-08-25 |
| Prosight Fund, LP | Institution | 474 159 | 0,62% | US$ 3,05M | 2024-09-30 |
| Redmile Strategic Trading Sub, Ltd. | Institution | 467 910 | 0,61% | US$ 3,01M | 2025-08-25 |
| Redmile Capital Fund, LP | Institution | 456 784 | 0,60% | US$ 2,94M | 2025-08-25 |
| S & G Foundation | Institution | 435 749 | 0,57% | US$ 2,81M | 2026-03-31 |
| Jane Street Group, LLC | Institution | 415 938 | 0,54% | US$ 2,68M | 2026-03-31 |
| FMR LLC | Institution | 392 500 | 0,51% | US$ 2,53M | 2026-03-31 |
| TD Asset Management, Inc. | Institution | 382 648 | 0,50% | US$ 2,46M | 2026-03-31 |
| Redmile Capital Offshore Fund II, Ltd | Institution | 374 149 | 0,49% | US$ 2,41M | 2025-08-25 |
| Vanguard Fiduciary Trust Company | Institution | 324 588 | 0,42% | US$ 2,09M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 316 012 | 0,41% | US$ 2,04M | 2026-03-31 |
| Redmile Strategic Long Only Trading Sub, Ltd. | Institution | 301 022 | 0,39% | US$ 1,94M | 2025-08-25 |
| Diadema Partners LP | Institution | 293 664 | 0,38% | US$ 1,89M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.